NanoViricides Inc. (NNVC)

[loanranger]

Let's ignore the TA crap for a minute....

....and look at a little bit of actual history. Click on the 1Y chart on the right as a reference.

On 1/21 of this year the share price closed at $1.21.
During the following 2 months the company issued the following press releases (read bottom to top for proper sequence):

03/21/2016 NanoViricides, Inc. CEO Dr. Seymour Interview by Small Cap Nation is on YouTube
02/22/2016 NanoViricides' Anti-Virus Technology Published in Handbook of Clinical Nanomedicine
02/16/2016 NanoViricides Signs Agreement for Ocular Testing of Its Drug Candidates for the Treatment of Herpes Keratitis with the Baylor...
02/11/2016 NanoViricides Signs Agreement for Ocular Testing of Its Drug Candidates for the Treatment of Herpes Keratitis with the Univer...
02/10/2016 NanoViricides Files Quarterly Report for Period Ending 2015-12-31
02/09/2016 Quarterly Report (10-q)
02/08/2016 NanoViricides CEO to Present at the 18th Annual BIOCEO & Investor Conference on February 8, 2016 and at the Disruptive Growth...
02/01/2016 NanoViricides Signs Agreement with the University of Wisconsin for Testing of Anti-Viral Candidates
http://ih.advfn.com/p.php?pid=news&symbol=A%5ENNVC

On 3/21 the share price was $3.27, representing a 170% increase during the period in which the company issued those releases. I don't think that it would be reckless to suggest that the increase was as a direct result of those press releases. While, if I'm not mistaken, trading volume tends to accelerate price movement in either direction, it's probably pretty safe to attribute the TREND to the news.

Unfortunately that $3.27 was as good as it got for NNVC and the trend since that day has been down.

The only thing noteworthy that happened on 3/21 was the press release issued on that date, which can be seen here:
http://ih.advfn.com/p.php?pid=nmona&article=70837027

The release doesn't include any bad news (of course). It generally reiterates the status issues described in the releases that preceded it, referencing the comments of CEO Seymour as made in an interview that the release encouraged readers to watch on YouTube, providing the web address for that interview (

).
The three testing agreements announced in the releases were fairly recent at that point so there shouldn't have been an expectation of any significant updates regarding the status of the testing and indeed there weren't any such updates. There was NOTHING in that release that should have triggered the inexorable downward trend that began the following day. But there was THAT interview. Maybe it was the interview...and I'm not necessarily referring to the words of it, but rather the visual. I've watched the whole thing several times and I can't do it again, finding it sad and disturbing. Maybe it's me, but share prices are forward looking and in that regard the picture presented by the CEO wasn't filled with promise as I saw it. I can think of several aging gentleman scientists who lack(ed) visual appeal yet provid(ed) compelling interviews, but they had serious accomplishments for background. This is the CEO of a company that has done many things without completing any of them. That fact hurts his credibility and the visual does nothing to restore it.


Of course SINCE 3/21 there has been no significant update on the testing announcements that moved the price up in the first place (except the one-liner buried in the recent 10-K: "the Baylor program is currently on hold due to lack of personnel to advance it at the site") and that may very well account for the trend to today's share price. The Baylor situation wasn't addressed in the "NanoViricides Has Filed Annual Report" press release, itself a few weeks later than it was expected.
Which beings me to the CEO letter. I wonder if there's any chance that the coincidence of the CEO's publicized, linked interview and the exact top of the 1Y mountain pictured to the right of this post has left the powers-that-be wondering about the public face of NNVC. Obviously there is no visual in a letter, but it might serve as a reminder.


BTW this comment, which the CEO must have expected to be published, exhibits some special kind of bad judgment:
"There’s been endless speculation as to why I haven’t released my letter
The reason is very simple
I went to the plant this week and showed it to the staff
Everyone said it looked as if a scientist had written it (big surprise) and it just didn’t “flow"
I’m interviewing some professional writers over the weekend"

The man's job is almost exclusively public/investor relations with at least one of its goals to communicate with the public, inspiring confidence in the company in the process and thereby providing some support for the marketability of its shares. The little note above does nothing positive in that regard. To the contrary it highlights a weakness. Someone at the company might want to consider editing his public statements. Perhaps the lack of a CEO letter represents such an attempt.